ReviewThe Japanese dental science review2024
Organic antibacterial modifications of high-viscosity glass ionomer cement for atraumatic restorative treatment: A review.
Review in The Japanese dental science review, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 11 citations in OpenAlex.
- Evaluations of high-viscosity glass-ionomer cement modified by eucalyptus extract-loaded mesoporous silica nanoparticles: in vitro study.Odontology · 2026Article
- Effect of Titanium Dioxide (TiOMaterials (Basel, Switzerland) · 2026Review
- Biological evaluation of resin-modified glass ionomer cement containing coumarin derivatives for dental application.Journal of Taibah University Medical Sciences · 2026Article
- Leveraging Dental Biotechnology for Population Oral Health: Innovations in Prevention, Diagnosis, and Treatment.International journal of molecular sciences · 2025Review
- Strategies for Restoration of Compromised First Permanent Molars in Children: Challenges and Optimal Timing.Oral health & preventive dentistry · 2025Review
- Glass Ionomer Cements with Halloysite-CHX: Physicochemical Properties, Antimicrobial Activity, Cell Viability.Brazilian dental journal · 2025Article
- Updates on the clinical application of glass ionomer cement in restorative and preventive dentistry.Journal of dental sciences · 2024Review
- Bioactive Compounds Enhance the Biocompatibility and the Physical Properties of a Glass Ionomer Cement.Journal of functional biomaterials · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
High viscosity glass ionomer cement (HVGIC) has been employed as a restorative material for Atraumatic Restorative Treatment (ART). As residual caries persist after caries removal in ART, the antibacterial activity of HVGIC gains importance. Organic and inorganic substances with antibacterial properties have been incorporated into HVGIC over the years, and their effects on the antibacterial and physical properties have been studied. The objective of this paper is to review the various alterations made to HVGIC using organic compounds, their effect on the antibacterial activity, and the physical properties of the cement. Various in vitro investigations have been conducted by adding antiseptics, antibiotics, and naturally occurring antibacterial substances. Most of these compounds render superior antibacterial properties to HVGIC, but higher concentrations affect physical properties in a dose-dependent manner. However, some naturally occurring antibacterial substances, such as chitosan, improve the physical properties of HVGIC, as they enhance cross-linking and polysalt bridging. There is potential for clinical benefits to be gained from the addition of organic antibacterial compounds to HVGIC. In-depth research is required to determine the optimum concentration at which the antibacterial effect is maximum without affecting the physical properties of the cement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.